HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Construction, affinity maturation, and biological characterization of an anti-tumor-associated glycoprotein-72 humanized antibody.

Abstract
The tumor-associated glycoprotein (TAG)-72 is expressed in the majority of human adenocarcinomas but is rarely expressed in most normal tissues, which makes it a potential target for the diagnosis and therapy of a variety of human cancers. Here we describe the construction, affinity maturation, and biological characterization of an anti-TAG-72 humanized antibody with minimum potential immunogenicity. The humanized antibody was constructed by grafting only the specificity-determining residues (SDRs) within the complementarity-determining regions (CDRs) onto homologous human immunoglobulin germ line segments while retaining two mouse heavy chain framework residues that support the conformation of the CDRs. The resulting humanized antibody (AKA) showed only about 2-fold lower affinity compared with the original murine monoclonal antibody CC49 and 27-fold lower reactivity to patient serum compared with the humanized antibody HuCC49 that was constructed by CDR grafting. The affinity of AKA was improved by random mutagenesis of the heavy chain CDR3 (HCDR3). The highest affinity variant (3E8) showed 22-fold higher affinity compared with AKA and retained the original epitope specificity. Mutational analysis of the HCDR3 residues revealed that the replacement of Asn(97) by isoleucine or valine was critical for the affinity maturation. The 3E8 labeled with (125)I or (131)I showed efficient tumor targeting or therapeutic effects, respectively, in athymic mice with human colon carcinoma xenografts, suggesting that 3E8 may be beneficial for the diagnosis and therapy of tumors expressing TAG-72.
AuthorsSun Ok Yoon, Tae Sup Lee, Sang Jick Kim, Myung Hee Jang, Young Jun Kang, Jae Hyun Park, Keun-Soo Kim, Hyun Sil Lee, Chun Jeih Ryu, Noreen R Gonzales, Syed V S Kashmiri, Sang Moo Lim, Chang Woon Choi, Hyo Jeong Hong
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 281 Issue 11 Pg. 6985-92 (Mar 17 2006) ISSN: 0021-9258 [Print] United States
PMID16407221 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies
  • Antigens, Neoplasm
  • Complementarity Determining Regions
  • Glycoproteins
  • Immunoglobulin G
  • Protein Isoforms
  • Recombinant Proteins
  • tumor-associated antigen 72
Topics
  • Adenocarcinoma (metabolism)
  • Amino Acid Sequence
  • Animals
  • Antibodies (chemistry)
  • Antigens, Neoplasm (chemistry, immunology)
  • Binding, Competitive
  • COS Cells
  • Cell Line, Tumor
  • Chlorocebus aethiops
  • Complementarity Determining Regions
  • Dose-Response Relationship, Immunologic
  • Escherichia coli (metabolism)
  • Female
  • Genetic Variation
  • Glycoproteins (chemistry, immunology)
  • Humans
  • Immunoglobulin G (chemistry)
  • Kinetics
  • Mice
  • Mice, Inbred BALB C
  • Molecular Conformation
  • Molecular Sequence Data
  • Neoplasm Transplantation
  • Polymerase Chain Reaction
  • Protein Binding
  • Protein Isoforms
  • Protein Structure, Tertiary
  • Recombinant Proteins (chemistry)
  • Sequence Homology, Amino Acid
  • Surface Plasmon Resonance
  • Time Factors
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: